Compare · DASH vs GDRX
DASH vs GDRX
Side-by-side comparison of DoorDash Inc. (DASH) and GoodRx Holdings Inc. (GDRX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DASH and GDRX operate in EDP Services (Technology), so they compete in similar markets.
- DASH is the larger of the two at $35.57B, about 39.9x GDRX ($890.7M).
- Over the past year, DASH is down 29.9% and GDRX is down 36.0% - DASH leads by 6.1 points.
- DASH has been more active in the news (18 items in the past 4 weeks vs 3 for GDRX).
- Both have 25 recent analyst ratings on file.
- Company
- DoorDash Inc.
- GoodRx Holdings Inc.
- Price
- $152.45-2.79%
- $2.63-0.94%
- Market cap
- $35.57B
- $890.7M
- 1M return
- -11.10%
- -7.07%
- 1Y return
- -29.91%
- -36.01%
- Industry
- EDP Services
- EDP Services
- Exchange
- NYSE
- NASDAQ
- IPO
- 2020
- News (4w)
- 18
- 3
- Recent ratings
- 25
- 25
DoorDash Inc.
DoorDash, Inc. operates a logistics platform that connects merchants, consumers, and dashers in the United States and internationally. It operates DoorDash marketplace, which provides an array of services that enable merchants to solve mission-critical challenges, such as customer acquisition, delivery, insights and analytics, merchandising, payment processing, and customer support; and offers DoorDash Drive, a white-label logistics service; DoorDash Storefront that enables merchants to offer consumers on-demand access to e-commerce. The company was formerly known as Palo Alto Delivery Inc. and changed its name to DoorDash, Inc. in 2015. DoorDash, Inc. was founded in 2013 and is headquartered in San Francisco, California.
GoodRx Holdings Inc.
GoodRx Holdings, Inc., through its subsidiaries, provides information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including telehealth services. The company serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. GoodRx Holdings, Inc. was incorporated in 2015 and is based in Santa Monica, California.
Latest DASH
- Director Kovac Milan bought $6,237 worth of shares (40 units at $155.94), increasing direct ownership by 2% to 1,942 units (SEC Form 4)
- Director Tang Stanley acquired 23,125 shares as part of a pre-agreed trading plan and sold $3,646,189 worth of shares (23,125 units at $157.67) as part of a pre-agreed trading plan (SEC Form 4)
- DoorDash Ads Becomes a Global Commerce Media Platform
- CHIEF BUSINESS OFFICER Yandell Keith sold $410,576 worth of shares (2,643 units at $155.34) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 81,106 units (SEC Form 4)
- PRESIDENT AND COO Adarkar Prabir exercised 10,000 shares at a strike of $7.16 and sold $3,375,042 worth of shares (21,739 units at $155.25) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 959,076 units (SEC Form 4)
- DoorDash, Deliveroo and Wolt Debut First-Ever International Campaign Celebrating the FIFA World Cup 2026™
- Summer of DashPass Is Back to Help Fans Make the Most of FIFA World Cup 2026™
- DoorDash and Dollar Tree Partner to Bring Greater Value and Thrill of the Hunt Discovery On-Demand
- GENERAL COUNSEL AND SECRETARY Sherringham Tia sold $441,047 worth of shares (2,743 units at $160.79) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 128,216 units (SEC Form 4)
- CHIEF ACCOUNTING OFFICER Lee Gordon S exercised 2,000 shares at a strike of $17.57 and sold $354,381 worth of shares (2,204 units at $160.79) as part of a pre-agreed trading plan, decreasing direct ownership by 0.23% to 89,447 units (SEC Form 4)
Latest GDRX
- Director Hirsch Douglas Joseph was granted 4,642 shares, increasing direct ownership by 2% to 247,502 units (SEC Form 4)
- Director Bruehlman Ronald E was granted 4,642 shares, increasing direct ownership by 4% to 133,918 units (SEC Form 4)
- GoodRx Launches GoodRx Companion, a New Subscription Designed to Lower Everyday Healthcare Costs
- Chief Accounting Officer Chan Thomas (Tc) converted options into 5,575 shares and covered exercise/tax liability with 2,838 shares, increasing direct ownership by 274% to 3,737 units (SEC Form 4)
- Officer Mcginnis Christopher A covered exercise/tax liability with 19,726 shares and converted options into 44,779 shares, increasing direct ownership by 16% to 177,616 units (SEC Form 4)
- SEC Form 144 filed by GoodRx Holdings Inc.
- SEC Form 4 filed by Chief Accounting Officer Chan Thomas (Tc)
- SEC Form 10-Q filed by GoodRx Holdings Inc.
- GoodRx Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- GoodRx Reports First Quarter 2026 Results